ARKK has shown a strong rebound this year, outperforming major indices. Despite past performance concerns, Cathie Wood remains optimistic about innovation investing. Critics like Michael Burry and Morningstar point to risk management and concentration issues. Wood remains committed to her strategy with recent investments in genomics.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay